Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/30467
Title: Association between blood‐based protein biomarkers and brain MRI in the Alzheimer’s disease continuum: A systematic review
Authors: Mitolo, M
Lombardi, G
Manca, R
Nacmias, B
Venneri, A
Issue Date: 9-Jan-2025
Publisher: Wiley on behalf of Alzheimer's Association
Citation: Mitolo, M, et al. (2024) 'Association between blood‐based protein biomarkers and brain MRI in the Alzheimer’s disease continuum: A systematic review', Alzheimer's and Dementia, 20 (S8 Supplement: Developing Topics), e095097, pp. 1 - 2. doi: 10.1002/alz.095097.
Abstract: Background: Blood-based biomarkers are becoming emerging tools, easily detectable and minimally invasive, to reveal neurodegeneration and neuroinflammation in Alzheimer’s disease (AD). However, a comprehensive and up-to-date overview of the association between blood-based biomarkers and brain parameters as measured by MRI is not available. The aim of this review is to fill this gap and clarify the relationship between the main peripheral blood-based protein biomarkers (i.e., Aβ, p-tau, t-tau, NfL and GFAP) and brain parameters derived from MRI in the AD continuum. Method: A literature search was carried out searching the PubMed and Web of Science databases for articles published up to May 2023. Articles were excluded according to the following criteria: no data on protein biomarkers; no data on the association between biomarkers and MRI data; articles not presenting novel data; articles that included only cognitively unimpaired older adults or patients with other neurological conditions; animal studies; molecular imaging studies; non-peer reviewed articles; non-English language articles; case reports. Result: A total of 33 articles were included in this systematic review. The findings revealed the following: hippocampal volume was positively correlated with Aβ42 and Aβ42/Aβ40 and negatively with Aβ40 plasma levels; p-tau181 and p-tau217 concentrations were negatively correlated with temporal grey matter volume and cortical thickness; NfL levels were negatively correlated with white matter microstructural integrity, whereas GFAP levels were positively correlated with myo-inositol values in the posterior cingulate cortex/precuneus. Moreover, higher plasma GFAP levels were also negatively associated with hippocampal atrophy, lower cortical thickness, and smaller white matter volumes in temporal and parietal regions. Conclusion: Our systematic review showed strong associations between the main blood-based protein biomarkers and MRI markers of AD, highlighting a high degree of concordance between these measurements. This suggests a possible advantage in combining multiple AD-related markers to improve accuracy of early diagnosis, prognosis, progression monitoring and treatment response.
Description: Poster presentation at AAIC 2024, Philadelphia, PA, USA, 28 July - 1 August 2024.
URI: https://bura.brunel.ac.uk/handle/2438/30467
DOI: https://doi.org/10.1002/alz.095097
ISSN: 1552-5260
Other Identifiers: ORCiD: Riccardo Manca https://orcid.org/0000-0003-1715-6442
ORCiD: Annalena Venneri https://orcid.org/0000-0002-9488-2301
e095097
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
MeetingAbstract.pdfCopyright © 2024 The Alzheimer’s Association. Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.70.07 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons